BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Antao AM, Tyagi A, Kim KS, Ramakrishna S. Advances in Deubiquitinating Enzyme Inhibition and Applications in Cancer Therapeutics. Cancers (Basel) 2020;12:E1579. [PMID: 32549302 DOI: 10.3390/cancers12061579] [Cited by in Crossref: 18] [Cited by in F6Publishing: 35] [Article Influence: 9.0] [Reference Citation Analysis]
Number Citing Articles
1 Tyagi A, Kaushal K, Chandrasekaran AP, Sarodaya N, Das S, Park CH, Hong SH, Kim KS, Ramakrishna S. CRISPR/Cas9-based genome-wide screening for deubiquitinase subfamily identifies USP1 regulating MAST1-driven cisplatin-resistance in cancer cells. Theranostics 2022;12:5949-70. [PMID: 35966591 DOI: 10.7150/thno.72826] [Reference Citation Analysis]
2 Li B, Wang B. USP7 Enables Immune Escape of Glioma Cells by Regulating PD-L1 Expression. Immunological Investigations. [DOI: 10.1080/08820139.2022.2083972] [Reference Citation Analysis]
3 Doherty LM, Mills CE, Boswell SA, Liu X, Hoyt CT, Gyori B, Buhrlage SJ, Sorger PK. Integrating multi-omics data reveals function and therapeutic potential of deubiquitinating enzymes. Elife 2022;11:e72879. [PMID: 35737447 DOI: 10.7554/eLife.72879] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
4 Hwang JT, Lee A, Kho C. Ubiquitin and Ubiquitin-like Proteins in Cancer, Neurodegenerative Disorders, and Heart Diseases. Int J Mol Sci 2022;23:5053. [PMID: 35563444 DOI: 10.3390/ijms23095053] [Reference Citation Analysis]
5 Xue J, Chen S, Ge D, Yuan X. Ultrasound-targeted microbubble destruction-mediated silencing of FBXO11 suppresses development of pancreatic cancer. Hum Cell 2022. [PMID: 35437704 DOI: 10.1007/s13577-022-00700-w] [Reference Citation Analysis]
6 Buneeva O, Medvedev A. Atypical Ubiquitination and Parkinson's Disease. Int J Mol Sci 2022;23:3705. [PMID: 35409068 DOI: 10.3390/ijms23073705] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
7 Yadav D, Lee JY, Puranik N, Chauhan PS, Chavda V, Jin J, Lee PCW. Modulating the Ubiquitin–Proteasome System: A Therapeutic Strategy for Autoimmune Diseases. Cells 2022;11:1093. [DOI: 10.3390/cells11071093] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Pellegrino NE, Guven A, Gray K, Shah P, Kasture G, Nastke MD, Thakurta A, Gesta S, Vishnudas VK, Narain NR, Kiebish MA. The Next Frontier: Translational Development of Ubiquitination, SUMOylation, and NEDDylation in Cancer. Int J Mol Sci 2022;23:3480. [PMID: 35408841 DOI: 10.3390/ijms23073480] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
9 Yang Q, Chen Y, Guo R, Dai Y, Tang L, Zhao Y, Wu X, Li M, Du F, Shen J, Yi T, Xiao Z, Wen Q. Interaction of ncRNA and Epigenetic Modifications in Gastric Cancer: Focus on Histone Modification. Front Oncol 2021;11:822745. [PMID: 35155211 DOI: 10.3389/fonc.2021.822745] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
10 Hu G, Yang J, Zhang H, Huang Z, Yang H. OTUB2 Promotes Proliferation and Migration of Hepatocellular Carcinoma Cells by PJA1 Deubiquitylation. Cel Mol Bioeng . [DOI: 10.1007/s12195-022-00720-4] [Reference Citation Analysis]
11 Kaushal K, Tyagi A, Karapurkar JK, Kim EJ, Tanguturi P, Kim KS, Jung HS, Ramakrishna S. Genome-Wide CRISPR/Cas9-Based Screening for Deubiquitinase Subfamily Identifies Ubiquitin-Specific Protease 11 as a Novel Regulator of Osteogenic Differentiation. Int J Mol Sci 2022;23:856. [PMID: 35055037 DOI: 10.3390/ijms23020856] [Reference Citation Analysis]
12 Xie Y, Wang M, Xia M, Guo Y, Zu X, Zhong J. Ubiquitination regulation of aerobic glycolysis in cancer. Life Sci 2022;292:120322. [PMID: 35031261 DOI: 10.1016/j.lfs.2022.120322] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
13 Cheng CP, Liu ST, Chiu YL, Huang SM, Ho CL. The Inhibitory Effects of 6-Thioguanine and 6-Mercaptopurine on the USP2a Target Fatty Acid Synthase in Human Submaxillary Carcinoma Cells. Front Oncol 2021;11:749661. [PMID: 34956872 DOI: 10.3389/fonc.2021.749661] [Reference Citation Analysis]
14 Staszczak M. Fungal Secondary Metabolites as Inhibitors of the Ubiquitin-Proteasome System. Int J Mol Sci 2021;22:13309. [PMID: 34948102 DOI: 10.3390/ijms222413309] [Reference Citation Analysis]
15 Dai X, Zhang T, Hua D. Ubiquitination and SUMOylation: protein homeostasis control over cancer. Epigenomics 2022;14:43-58. [PMID: 34875856 DOI: 10.2217/epi-2021-0371] [Reference Citation Analysis]
16 Liu L, Yang Y, Fang R, Zhu W, Wu J, Li X, Patankar JV, Li W. Giardia duodenalis and Its Secreted PPIB Trigger Inflammasome Activation and Pyroptosis in Macrophages through TLR4-Induced ROS Signaling and A20-Mediated NLRP3 Deubiquitination. Cells 2021;10:3425. [PMID: 34943932 DOI: 10.3390/cells10123425] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
17 Zhang Z, Cui Z, Xie Z, Li C, Xu C, Guo X, Yu J, Chen T, Facchinetti F, Bohnenberger H, Leong TL, Xie Y, Mao X, Zhao J. Deubiquitinase USP5 promotes non-small cell lung cancer cell proliferation by stabilizing cyclin D1. Transl Lung Cancer Res 2021;10:3995-4011. [PMID: 34858787 DOI: 10.21037/tlcr-21-767] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
18 Tyagi A, Haq S, Ramakrishna S. Redox regulation of DUBs and its therapeutic implications in cancer. Redox Biol 2021;48:102194. [PMID: 34814083 DOI: 10.1016/j.redox.2021.102194] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
19 Sun T, Liu Z, Bi F, Yang Q. Deubiquitinase PSMD14 promotes ovarian cancer progression by decreasing enzymatic activity of PKM2. Mol Oncol 2021. [PMID: 34382324 DOI: 10.1002/1878-0261.13076] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
20 Yan D, Li X, Yang Q, Huang Q, Yao L, Zhang P, Sun W, Lin S, Dou QP, Liu J, Chen X. Regulation of Bax-dependent apoptosis by mitochondrial deubiquitinase USP30. Cell Death Discov 2021;7:211. [PMID: 34381024 DOI: 10.1038/s41420-021-00599-6] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
21 Jing C, Liu D, Lai Q, Li L, Zhou M, Ye B, Wu Y, Li H, Yue K, Wu Y, Duan Y, Wang X. JOSD1 promotes proliferation and chemoresistance of head and neck squamous cell carcinoma under the epigenetic regulation of BRD4. Cancer Cell Int 2021;21:375. [PMID: 34261480 DOI: 10.1186/s12935-021-02060-1] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
22 Miles X, Vandevoorde C, Hunter A, Bolcaen J. MDM2/X Inhibitors as Radiosensitizers for Glioblastoma Targeted Therapy. Front Oncol 2021;11:703442. [PMID: 34307171 DOI: 10.3389/fonc.2021.703442] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
23 Sorrentino VG, Thota S, Gonzalez EA, Rameshwar P, Chang VT, Etchegaray JP. Hypomethylating Chemotherapeutic Agents as Therapy for Myelodysplastic Syndromes and Prevention of Acute Myeloid Leukemia. Pharmaceuticals (Basel) 2021;14:641. [PMID: 34358067 DOI: 10.3390/ph14070641] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
24 Jang SW, Kim JM. Mutation of aspartic acid 199 in USP1 disrupts its deubiquitinating activity and impairs DNA repair. FEBS Lett 2021;595:1997-2006. [PMID: 34128540 DOI: 10.1002/1873-3468.14152] [Reference Citation Analysis]
25 Zhu Y, Xu J, Hu W, Wang F, Zhou Y, Gong W, Xu W. Inhibiting USP8 overcomes hepatocellular carcinoma resistance via suppressing receptor tyrosine kinases. Aging (Albany NY) 2021;13:14999-5012. [PMID: 34081623 DOI: 10.18632/aging.203061] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
26 Chandrasekaran AP, Suresh B, Sarodaya N, Ko NR, Oh SJ, Kim KS, Ramakrishna S. Ubiquitin Specific Protease 29 Functions as an Oncogene Promoting Tumorigenesis in Colorectal Carcinoma. Cancers (Basel) 2021;13:2706. [PMID: 34072621 DOI: 10.3390/cancers13112706] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
27 Chandrasekaran AP, Woo SH, Sarodaya N, Rhie BH, Tyagi A, Das S, Suresh B, Ko NR, Oh SJ, Kim KS, Ramakrishna S. Ubiquitin-Specific Protease 29 Regulates Cdc25A-Mediated Tumorigenesis. Int J Mol Sci 2021;22:5766. [PMID: 34071237 DOI: 10.3390/ijms22115766] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
28 Duan B, Wang C, Liu Z, Yang X. USP8 is a Novel Therapeutic Target in Melanoma Through Regulating Receptor Tyrosine Kinase Levels. Cancer Manag Res 2021;13:4181-9. [PMID: 34079371 DOI: 10.2147/CMAR.S300195] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
29 Kyca T, Pavlíková L, Boháčová V, Mišák A, Poturnayová A, Breier A, Sulová Z, Šereš M. Insight into Bortezomib Focusing on Its Efficacy against P-gp-Positive MDR Leukemia Cells. Int J Mol Sci 2021;22:5504. [PMID: 34071136 DOI: 10.3390/ijms22115504] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
30 Guo H, Li Y, Liu Y, Chen L, Gao Z, Zhang L, Zhou N, Guo H, Shi B. Prognostic Role of the Ubiquitin Proteasome System in Clear Cell Renal Cell Carcinoma: A Bioinformatic Perspective. J Cancer 2021;12:4134-47. [PMID: 34093816 DOI: 10.7150/jca.53760] [Reference Citation Analysis]
31 Tyagi A, Sarodaya N, Kaushal K, Chandrasekaran AP, Antao AM, Suresh B, Rhie BH, Kim KS, Ramakrishna S. E3 Ubiquitin Ligase APC/CCdh1 Regulation of Phenylalanine Hydroxylase Stability and Function. Int J Mol Sci 2020;21:E9076. [PMID: 33260674 DOI: 10.3390/ijms21239076] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
32 Kaushal K, Woo SH, Tyagi A, Kim DH, Suresh B, Kim KS, Ramakrishna S. E3 Ubiquitin Ligase APC/CCdh1 Negatively Regulates FAH Protein Stability by Promoting Its Polyubiquitination. Int J Mol Sci 2020;21:E8719. [PMID: 33218190 DOI: 10.3390/ijms21228719] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
33 Park J, Cho J, Song EJ. Ubiquitin-proteasome system (UPS) as a target for anticancer treatment. Arch Pharm Res 2020;43:1144-61. [PMID: 33165832 DOI: 10.1007/s12272-020-01281-8] [Cited by in Crossref: 14] [Cited by in F6Publishing: 38] [Article Influence: 7.0] [Reference Citation Analysis]
34 Sun T, Liu Z, Yang Q. The role of ubiquitination and deubiquitination in cancer metabolism. Mol Cancer 2020;19:146. [PMID: 33004065 DOI: 10.1186/s12943-020-01262-x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 50] [Article Influence: 4.0] [Reference Citation Analysis]
35 El-Mesery M, Anany MA, Hazem SH, Shaker ME. The NEDD8-activating enzyme inhibition with MLN4924 sensitizes human cancer cells of different origins to apoptosis and necroptosis. Arch Biochem Biophys 2020;691:108513. [PMID: 32721435 DOI: 10.1016/j.abb.2020.108513] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]